Evolution of surgical microwave ablation for the treatment of colorectal cancer liver metastasis: review of the literature and a single centre experience

Surgery Today

Volumn 45, Issue 4, 2015, Pages 407-415

  Stättner, Stefan ^a,b   Primavesi, Florian ^b   Yip, Vincent S ^a   Jones, Robert P ^a,c   Öfner, Dietmar ^b   Malik, Hassan Z ^a   Fenwick, Stephen W ^a   Poston, Graeme J ^a,c  

^a UNIVERSITY HOSPITAL AINTREE   (United Kingdom)

^b PARACELSUS MEDICAL UNIVERSITY   (Austria)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Colorectal cancer; Liver metastasis; Microwave ablation; Microwave coagulation; Surgery

Indexed keywords

ABLATION THERAPY; COLORECTAL NEOPLASMS; COMPUTER ASSISTED SURGERY; HUMAN; LAPAROSCOPY; LAPAROTOMY; LIVER NEOPLASMS; LIVER RESECTION; MICROWAVE RADIATION; PATHOLOGY; PROCEDURES; SECONDARY; THERAPEUTIC USE;

ABLATION TECHNIQUES; COLORECTAL NEOPLASMS; HEPATECTOMY; HUMANS; LAPAROSCOPY; LAPAROTOMY; LIVER NEOPLASMS; MICROWAVES; SURGERY, COMPUTER-ASSISTED;

EID: 84895932784     PISSN: 09411291     EISSN: 14362813     Source Type: Journal    
DOI: 10.1007/s00595-014-0879-3     Document Type: Review

References (64)

1. Poston GJ, Tait D, O’Connell S, Bennett A, Berendse S. Diagnosis and management of colorectal cancer: summary of NICE guidance. BMJ. 2011;343:d6751.
2. Cirocchi R, Trastulli S, Boselli C, Montedori A, Cavaliere D, Parisi A, et al. Radiofrequency ablation in the treatment of liver metastases from colorectal cancer. Cochrane Database Syst Rev. 2012;6:CD006317.
3. Jones C, Badger SA, Ellis G. The role of microwave ablation in the management of hepatic colorectal metastases. Surgeon. 2011;9:33–7.
4. Hugh TJ, Kinsella AR, Poston GJ. Management strategies for colorectal liver metastases: part II. Surg Oncol. 1997;6:31–48.
5. Pawlik TM, Choti MA. Surgical therapy for colorectal metastases to the liver. J Gastrointest Surg. 2007;11:1057–77.
6. Jones RP, Jackson R, Dunne DF, Malik HZ, Fenwick SW, Poston GJ, et al. Systematic review and meta-analysis of follow-up after hepatectomy for colorectal liver metastases. Br J Surg. 2012;99:477–86.
7. Adam R, Avisar E, Ariche A, Giachetti S, Azoulay D, Castaing D, et al. Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal [liver] metastases. Ann Surg Oncol. 2001;8:347–53.
8. Bismuth H, Adam R, Levi F, Farabos C, Waechter F, Castaing D, et al. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg. 1996;224:509–20.
9. Abdalla EK, Hicks ME, Vauthey JN. Portal vein embolization: rationale, technique and future prospects. Br J Surg. 2001;88:165–75.
10. Azoulay D, Castaing D, Smail A, Adam R, Cailliez V, Laurent A, et al. Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann Surg. 2000;231:480–6.
11. Adam R, Laurent A, Azoulay D, Castaing D, Bismuth H. Two-stage hepatectomy: a planned strategy to treat irresectable liver tumors. Ann Surg. 2000;232:777–85.
12. Kianmanesh R, Farges O, Abdalla EK, Sauvanet A, Ruszniewski P, Belghiti J. Right portal vein ligation: a new planned two-step all-surgical approach for complete resection of primary gastrointestinal tumors with multiple bilateral liver metastases. J Am Coll Surg. 2003;197:164–70.
13. Stättner S, Yip V, Jones RP, Lacasia C, Fenwick SW, Poston GJ, et al. Liver resection with concomitant inferior vena cava resection: experiences without veno-venous bypass. Surg Today. 2013. doi:10.1007/s00595-013-0652-z.
14. Derek E, Matsuoka L, Alexopoulos S, Fedenko A, Genyk Y, Selby R. Combined surgical resection and radiofrequency ablation as treatment for metastatic ocular melanoma. Surg Today. 2013;43(4):367–71.
15. Wong SL, Mangu PB, Choti MA, et al. American Society of Clinical Oncology 2009 clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer. J Clin Oncol. 2010;28(3):493–508.
16. NICE. Microwave ablation for the treatment of liver metastases 2011(Aug), p. N2640. Available at: http://www.nice.org.uk.
17. Pathak S, Jones R, Tang JM, Parmar C, Fenwick S, Malik H, et al. Ablative therapies for colorectal liver metastases: a systematic review. Colorectal Dis. 2011;13:e252–65.
18. Ruers T, Punt C, Van Coevorden F, Pierie JP, Borel-Rinkes I, Ledermann JA, et al. Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004). Ann Oncol. 2012;23:2619–26.
19. Evrard S, Rivoire M, Arnaud J, Lermite E, Bellera C, Fonck M, et al. Unresectable colorectal cancer liver metastases treated by intraoperative radiofrequency ablation with or without resection. Br J Surg. 2012;99:558–65.
20. Rocha FG, D’Angelica M. Treatment of liver colorectal metastases: role of laparoscopy, radiofrequency ablation, and microwave coagulation. J Surg Oncol. 2010;102:968–74.
21. Gravante G, Ong SL, Metcalfe MS, Strickland A, Dennison AR, Lloyd DM. Hepatic microwave ablation: a review of the histological changes following thermal damage. Liver Int. 2008;28:911–21.
22. Tabuse K. A new operative procedure of hepatic surgery using a microwave tissue coagulator. Nihon Geka Hokan. 1979;48:160–72.
23. Ong SL, Gravante G, Metcalfe MS, Strickland AD, Dennison AR, Lloyd DM. Efficacy and safety of microwave ablation for primary and secondary liver malignancies: a systematic review. Eur J Gastroenterol Hepatol. 2009;21:599–605.
24. Hoffmann R, Rempp H, Clasen S. Microwave tumor ablation. New devices, new applications? Radiologe. 2012;52:22–8.
25. Jones RP, Kitteringham NR, Terlizzo M, Hancock C, Dunne D, Fenwick SW, et al. Microwave ablation of ex vivo human liver and colorectal liver metastases with a novel 14.5 GHz generator. Int J Hyperthermia. 2012;28:43–54.
26. Ohmoto K, Yoshioka N, Tomiyama Y, Shibata N, Kawase T, Yoshida K, et al. Radiofrequency ablation versus percutaneous microwave coagulation therapy for small hepatocellular carcinomas: a retrospective comparative study. Hepatogastroenterology. 2007;54:985–9.
27. Lu MD, Xu HX, Xie XY, Yin XY, Chen JW, Kuang M, et al. Percutaneous microwave and radiofrequency ablation for hepatocellular carcinoma: a retrospective comparative study. J Gastroenterol. 2005;40:1054–60.
28. Dong B, Liang P, Yu X, Su L, Yu D, Cheng Z, et al. Percutaneous sonographically guided microwave coagulation therapy for hepatocellular carcinoma: results in 234 patients. AJR Am J Roentgenol. 2003;180:1547–55.
29. Shibata T, Iimuro Y, Yamamoto Y, Maetani Y, Ametani F, Itoh K, et al. Small hepatocellular carcinoma: comparison of radio-frequency ablation and percutaneous microwave coagulation therapy. Radiology. 2002;223:331–7.
30. Seki T, Tamai T, Nakagawa T, Imamura M, Nishimura A, Yamashiki N, et al. Combination therapy with transcatheter arterial chemoembolization and percutaneous microwave coagulation therapy for hepatocellular carcinoma. Cancer. 2000;89:1245–51.
31. Kuang M, Lu MD, Xie XY, Xu HX, Mo LQ, Liu GJ, et al. Liver cancer: increased microwave delivery to ablation zone with cooled-shaft antenna–experimental and clinical studies. Radiology. 2007;242:914–24.
32. Shibata T, Niinobu T, Ogata N, Takami M. Microwave coagulation therapy for multiple hepatic metastases from colorectal carcinoma. Cancer. 2000;89:276–84.
33. Tanaka K, Shimada H, Nagano Y, Endo I, Sekido H, Togo S. Outcome after hepatic resection versus combined resection and microwave ablation for multiple bilobar colorectal metastases to the liver. Surgery. 2006;139:263–73.
34. Iannitti DA, Martin RC, Simon CJ, Hope WW, Newcomb WL, McMasters KM, et al. Hepatic tumor ablation with clustered microwave antennae: the US Phase II trial. HPB (Oxford). 2007;9:120–4.
35. Martin RC, Scoggins CR, McMasters KM. Safety and efficacy of microwave ablation of hepatic tumors: a prospective review of a 5-year experience. Ann Surg Oncol. 2010;17:171–8.
36. Jagad RB, Koshariya M, Kawamoto J, Papastratis P, Kefalourous H, Patris V, et al. Laparoscopic microwave ablation of liver tumors: our experience. Hepatogastroenterology. 2008;55:27–32.
37. Bhardwaj N, Strickland AD, Ahmad F, El-Abassy M, Morgan B, Robertson GS, et al. Microwave ablation for unresectable hepatic tumours: clinical results using a novel microwave probe and generator. Eur J Surg Oncol. 2010;36:264–8.
38. Livraghi T, Meloni F, Solbiati L, Zanus G. Complications of microwave ablation for liver tumors: results of a multicenter study. Cardiovasc Intervent Radiol. 2012;35:868–74.
39. Seki T, Wakabayashi M, Nakagawa T, Imamura M, Tamai T, Nishimura A, et al. Percutaneous microwave coagulation therapy for solitary metastatic liver tumors from colorectal cancer: a pilot clinical study. Am J Gastroenterol. 1999;94:322–7.
40. Morita T, Shibata T, Okuyama M, Ikeda K, Tsukahara Y, Kitada M, et al. Microwave coagulation therapy for liver metastases from colorectal cancer. Gan To Kagaku Ryoho. 2004;31:695–9.
41. Karanicolas PJ, Jarnagin WR, Gonen M, Tuorto S, Allen PJ, Dematteo RP, et al. Long-term outcomes following tumor ablation for treatment of bilateral colorectal liver metastases. JAMA Surg. 2013;148:597–601.
42. Dodd GD 3rd, Dodd NA, Lanctot AC, Glueck DA. Effect of variation of portal venous blood flow on radiofrequency and microwave ablations in a blood-perfused bovine liver model. Radiology. 2013;267:129–36.
43. Bhardwaj N, Dormer J, Ahmad F, Strickland AD, Gravante G, West K, et al. Microwave ablation of the liver: a description of lesion evolution over time and an investigation of the heat sink effect. Pathology. 2011;43:725–31.
44. Yu NC, Raman SS, Kim YJ, Lassman C, Chang X, Lu DS. Microwave liver ablation: influence of hepatic vein size on heat-sink effect in a porcine model. J Vasc Interv Radiol. 2008;19:1087–92.
45. Ahmad F, Gravante G, Bhardwaj N, Strickland A, Basit R, West K, et al. Large volume hepatic microwave ablation elicits fewer pulmonary changes than radiofrequency or cryotherapy. J Gastrointest Surg. 2010;14:1963–8.
46. Ahmad F, Gravante G, Bhardwaj N, Strickland A, Basit R, West K, et al. Renal effects of microwave ablation compared with radiofrequency, cryotherapy and surgical resection at different volumes of the liver treated. Liver Int. 2010;30:1305–14.
47. Skonieczki BD, Wells C, Wasser EJ, Dupuy DE. Radiofrequency and microwave tumor ablation in patients with implanted cardiac devices: is it safe? Eur J Radiol. 2011;79:343–6.
48. Andreano A, Huang Y, Meloni MF, Lee FT Jr, Brace C. Microwaves create larger ablations than radiofrequency when controlled for power in ex vivo tissue. Med Phys. 2010;37:2967–73.
49. Simon CJ, Dupuy DE, Iannitti DA, Lu DS, Yu NC, Aswad BI, et al. Intraoperative triple antenna hepatic microwave ablation. AJR Am J Roentgenol. 2006;187:W333–40.
50. Garrean S, Hering J, Saied A, Helton WS, Espat NJ. Radiofrequency ablation of primary and metastatic liver tumors: a critical review of the literature. Am J Surg. 2008;195:508–20.
51. Garrean S, Hering J, Saied A, Hoopes PJ, Helton WS, Ryan TP, et al. Ultrasound monitoring of a novel microwave ablation (MWA) device in porcine liver: lessons learned and phenomena observed on ablative effects near major intrahepatic vessels. J Gastrointest Surg. 2009;13:334–40.
52. Lorentzen T, Skjoldbye BO, Nolsoe CP. Microwave ablation of liver metastases guided by contrast-enhanced ultrasound: experience with 125 metastases in 39 patients. Ultraschall Med. 2011;32:492–6.
53. Minami Y, Kudo M. Review of dynamic contrast-enhanced ultrasound guidance in ablation therapy for hepatocellular carcinoma. World J Gastroenterol. 2011;17:4952–9.
54. Byrd JF, Agee N, McKillop IH, Sindram D, Martinie JB, Iannitti DA. Colour doppler ultrasonography provides real-time microwave field visualisation in an ex vivo porcine model. HPB (Oxford). 2011;13:400–3.
55. Xu J, Jia ZZ, Song ZJ, Yang XD, Chen K, Liang P. Three-dimensional ultrasound image-guided robotic system for accurate microwave coagulation of malignant liver tumours. Int J Med Robot. 2010;6:256–68.
56. Elias D, Baton O, Sideris L, Matsuhisa T, Pocard M, Lasser P. Local recurrences after intraoperative radiofrequency ablation of liver metastases: a comparative study with anatomic and wedge resections. Ann Surg Oncol. 2004;11:500–5.
57. Adam R, Laurent A, Azoulay D, Castaing D, Bismuth H. Two-stage hepatectomy: a planned strategy to treat irresectable liver tumors. Ann Surg. 2000;232:777–85.
58. Wagmam LD. Importance of Response to Neoadjuvant Therapy in Patients With Liver-Limited mCRC When the Intent Is Resection and/or Ablation. Clin Colorectal Cancer. 2013;12:223–32.
59. Mima K, Beppu T, Chikamoto A, Miyamoto Y, Nakagawa S, Kuroki H, et al. Hepatic resection combined with radiofrequency ablation for initially unresectable colorectal liver metastases after effective chemotherapy is a safe procedure with a low incidence of local recurrence. Int J Clin Oncol. 2013;18:847–55.
60. Liang P, Dong B, Yu X, Yang Y, Yu D, Su L, et al. Prognostic factors for percutaneous microwave coagulation therapy of hepatic metastases. AJR Am J Roentgenol. 2003;181:1319–25.
61. Zhang X, Chen B, Hu S, Wang L, Wang K, Wachtel MS, et al. Microwave ablation with cooled-tip electrode for liver cancer: an analysis of 160 cases. Hepatogastroenterology. 2008;55:2184–7.
62. Ogata Y, Uchida S, Hisaka T, Horiuchi H, Mori S, Ishibashi N, et al. Intraoperative thermal ablation therapy for small colorectal metastases to the liver. Hepatogastroenterology. 2008;55:550–6.
63. Liang P, Wang Y, Yu X, Dong B. Malignant liver tumors: treatment with percutaneous microwave ablation-complications among cohort of 1136 patients. Radiology. 2009;251:933–40.
64. Stattner S, Jones RP, Yip VS, Buchanan K, Poston GJ, Malik HZ, et al. Microwave ablation with or without resection for colorectal liver metastases. Eur J Surg Oncol. 2013;39:844–9.